Navigation Links
Stereotaxis Reports Improved First Quarter 2012 Financial Results
Date:5/8/2012

ST. LOUIS, May 8, 2012 /PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today reported financial results for the first quarter ended March 31, 2012. 

Management Comments
Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis, said, "In the first quarter, we continued to capitalize on strong market response to the release of the Epoch™ Solution and robust utilization, realizing a 20% improvement in revenue over the prior year quarter. By quarter end, we had completed 25 upgrades to the Niobe® ES system in existing sites since its launch in December 2011; on pace with our forecast to achieve 40 upgraded sites during the first half of 2012. We expect Niobe® ES system sales will gain momentum throughout the year as we increase reference sites and optimize product value."

"We also improved operating loss by $4.6 million, or 52%, over last year through a combination of top line growth and significantly lower operating spend, which declined 21% year over year," continued Kaminski.

"In order to accelerate our timeline to achieve breakeven, we are executing a plan to reduce operating costs by an additional 15% to 20% without compromising our revenue growth strategies. With the Epoch™ Solution product development behind us, we can focus research dollars on enhancements that ensure market adoption and long-term success of the robotic platform. In addition, we have opportunity for greater efficiencies within our capital sales organization through alignment with our local clinical organization."These strategies, which are built on the successful commercial launch and improving revenue of the Niobe® ES system, position us to reach breakeven while continuing to refine our technology, expand our offering through the Vdrive™ product and leverage our strategic partners in global market opportunities," con
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
2. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
3. Stereotaxis Announces Public Offering of Common Stock
4. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
5. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
6. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
7. Stereotaxis System Procedure Featured on NBCs The TODAY Show
8. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
9. Stereotaxis Installs First System in Taiwan
10. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
11. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , Mar. 03, 2015 Research and Markets ... the "Blister Packaging Market in the US 2015-2019" ... Blister Packaging market in the US to grow at ... Blister packaging is a form of high-visibility packaging that ... pharmaceuticals. Blister packs comprise a base layer, made either ...
(Date:3/3/2015)... 3, 2015  BioPharmX Corporation (OTCQB: BPMX), a specialty ... delivery products to address unmet needs in large, well-defined ... , chief executive officer and co-founder of BioPharmX, will ... Partners Conference on Wednesday, March 11 at 9:00 a.m. ... in Dana Point , California.   ...
(Date:3/3/2015)... 2015 Konica Minolta Medical Imaging and Shimadzu ... a new, integrated portable X-ray solution, the MobileArt Evolution ... with a larger integrated console, and a 17" touch ... larger viewing area to simplify operation and enhance clinical ... accessories and storage, along with a detector slot that ...
Breaking Medicine Technology:United States Blister Packaging Market 2015-2019 - Growing Demand in Pharmaceuticals Industry with Amcor, Bemis, MeadWestvaco & Sonoco Products Dominating 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 3
... cancer,patients; Blinatumomab enables patients own T cells to recognize and attack ... ... Md., Aug. 14 Micromet, Inc.,(Nasdaq: MITI ), a biopharmaceutical ... autoimmune,diseases, today announced publication of a Phase 1 clinical study(1) on ...
... - Phase 2 development to begin in late 2008 ... Aug. 14 Nuvelo, Inc.,(Nasdaq: NUVO ) today ... NU172, demonstrating that the direct thrombin,inhibitor rapidly produced and ... infusion ended with a favorable safety,profile., "NU172 has ...
Cached Medicine Technology:Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4
(Date:3/3/2015)... IL (PRWEB) March 03, 2015 US ... high efficiency air purification systems, is pleased to announce that ... a brief supply interruption related to the west coast port ... is just around the corner. , The ... are expected to slow fourth quarter economic growth by as ...
(Date:3/3/2015)... Topical BioMedics, Inc., announces its March Pain Management Workshop will ... 10th, 12pm – 1pm and 4pm to 5pm. Afterward, ... , The Pain Management Workshops are free and open ... is “Opioid Addiction: An Over-Medicated Society.” It’s a ... the world’s population, yet consumers 99% of the world’s Vicodin ...
(Date:3/3/2015)... OH (PRWEB) March 03, 2015 ... to better predict antidepressant treatment outcomes for patients ... resources, than any of the individual genes that ... by investigators from the Mayo Clinic and Assurex ... i. , The proprietary technology of the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 -- vRad ( Virtual ... practice, today announced that Arlene Sussman, MD, a highly ... a live webinar to explore how telemedicine best practices ... imaging services for women virtually anywhere. Click here ... Service Line” on March 4, 2015 at 1:00 pm ...
(Date:3/3/2015)... 03, 2015 In a segment ... science correspondent Shankar Vedantam shared research ... the drastic decrease in hand-hygiene compliance that occurs over the ... problem could be solved in part by alerts on healthcare ... they enter and exit a patient’s room. , “Over ...
Breaking Medicine News(10 mins):Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3
... Health Minister Anbumani Ramadoss, has called a meeting of ... measures to be taken to control the mosquito-borne disease, ... Pradesh, Tamil Nadu, Kerala, Karnataka, Puducherry, Gujarat, Maharashtra, Goa ... ministry official said. ,The Ministers would also ...
... up a holistic tourism centre that will promote medical ... Kodiyeri Balakrishnan said here Wednesday . ... ayurveda, farm tourism and medical tourism," Balakrishnan told the ... Indian Industry (CII) was currently preparing a report for ...
... in normal peoples sleep. Some are light sleepers, whereas ... others take their time . ,Such ... differences in circumstances, habits, and other non-biological factors. But ... research professor and assistant director of the Sleep and ...
... procedures among most notable increases. Approximately 225,800 hair ... 34 percent from 2004, according to statistics ... by the International Society of Hair Restoration Surgery ... hair loss and hair restoration. ,This large ...
... at the Washington University School of Medicine in St. ... the butt by revealing that smoking interferes with ... a mouse model and found that cigarette smoking impairs ... delays healing following ligament repair surgery. ...
... Scientists at University of Alabama at Birmingham (UAB) have ... bacteria RNA and that in human RNA , a ... less antibiotic resistance. ,The new findings have ... Dmitry Vassylyev, Professor of Biochemistry and Molecular Genetics. ...
Cached Medicine News:Health News:Kerala to Set Up Holistic Tourism Centre to Promote Medical Tourism 2Health News:Individual Differences in Sleep Structure are Biologically Determined 2Health News:Hair Restoration Procedures Performed Worldwide Increased 34 Percent in 2006 2Health News:Hair Restoration Procedures Performed Worldwide Increased 34 Percent in 2006 3Health News:Smoking Hampers Healing of the Ligament 2Health News:Scientists Trace New Pathway That may Stem Antibiotic Resistance 2
... Used for percutaneous placement of ... renal pelvis for nephrostomy drainage ... Supplied sterile in peel-open packages. ... Periodic evaluation is advised; catheter ...
... a FAM-labeled probe and an Alexa 532-labeled probe ... region of the 5' UTR. This ASR requires ... and Texas Red reporter dyes like the Cepheid ... program is comprised of a series of easy-to-use ...
... The HSV Non-Typing ASR contains primers and ... a 92 bp region of the HSV Type ... requires an instrument that can detect a FAM ... The Cepheid Analyte Specific Reagent* (ASR) program is ...
... the perfect solution for your cyto- centrifuge ... snap-seal Filter Concentrators make operation easier than ... and conveniently on any bench or in ... to scan monolayer cell presentations of excellent ...
Medicine Products: